Market Overview
The global Sexually Transmitted Disease (STD) Diagnosis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Sexually Transmitted Disease (STD) Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Sexually Transmitted Disease (STD) Diagnosis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Sexually Transmitted Disease (STD) Diagnosis market has been segmented into Chlamydia testing, Syphilis testing, Gonorrhoea testing, Herpes simplex virus testing, Human papilloma virus testing, Human immunodeficiency virus testing, etc.
Breakdown by Application, Sexually Transmitted Disease (STD) Diagnosis has been segmented into Government organizations, Hospitals, Diagnostic clinics, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sexually Transmitted Disease (STD) Diagnosis market presented in the report. This section sheds light on the sales growth of different regional and country-level Sexually Transmitted Disease (STD) Diagnosis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sexually Transmitted Disease (STD) Diagnosis market.
For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Sexually Transmitted Disease (STD) Diagnosis Market Share Analysis
Sexually Transmitted Disease (STD) Diagnosis competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Sexually Transmitted Disease (STD) Diagnosis revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sexually Transmitted Disease (STD) Diagnosis revenue and market share for each player covered in this report.
The major players covered in Sexually Transmitted Disease (STD) Diagnosis are: Abbott, BioMérieux, Aposcience, Roche, Biocartis, Thermo Fisher Scientific, Cepheid, BD Medical, BCR Diagnostics, Bio-Rad, Hologic, Danaher, OraSure Technologies, GenMark Diagnostics, DiaSorin, Qualigen, Quidel, etc. Among other players domestic and global, Sexually Transmitted Disease (STD) Diagnosis market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market segment by players, this report covers
Abbott
BioMérieux
Aposcience
Roche
Biocartis
Thermo Fisher Scientific
Cepheid
BD Medical
BCR Diagnostics
Bio-Rad
Hologic
Danaher
OraSure Technologies
GenMark Diagnostics
DiaSorin
Qualigen
Quidel
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)
Market segment by Type, covers:
Chlamydia testing
Syphilis testing
Gonorrhoea testing
Herpes simplex virus testing
Human papilloma virus testing
Human immunodeficiency virus testing
Market segment by Application, can be divided into
Government organizations
Hospitals
Diagnostic clinics
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Sexually Transmitted Disease (STD) Diagnosis
1.2 Classification of Sexually Transmitted Disease (STD) Diagnosis by Type
1.2.1 Overview: Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type in 2019
1.2.3 Chlamydia testing
1.2.4 Syphilis testing
1.2.5 Gonorrhoea testing
1.2.6 Herpes simplex virus testing
1.2.7 Human papilloma virus testing
1.2.8 Human immunodeficiency virus testing
1.3 Global Sexually Transmitted Disease (STD) Diagnosis Market by Application
1.3.1 Overview: Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Government organizations
1.3.3 Hospitals
1.3.4 Diagnostic clinics
1.4 Global Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
1.5 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Regions (2015-2020)
1.7 Global Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2015-2025)
1.7.2 Europe Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2015-2025)
1.7.3 Asia Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2015-2025)
1.7.4 South America Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.2 BioMérieux
2.2.1 BioMérieux Details
2.2.2 BioMérieux Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 BioMérieux SWOT Analysis
2.2.4 BioMérieux Product and Services
2.2.5 BioMérieux Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.3 Aposcience
2.3.1 Aposcience Details
2.3.2 Aposcience Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Aposcience SWOT Analysis
2.3.4 Aposcience Product and Services
2.3.5 Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.5 Biocartis
2.5.1 Biocartis Details
2.5.2 Biocartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Biocartis SWOT Analysis
2.5.4 Biocartis Product and Services
2.5.5 Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Thermo Fisher Scientific SWOT Analysis
2.6.4 Thermo Fisher Scientific Product and Services
2.6.5 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cepheid
2.7.1 Cepheid Details
2.7.2 Cepheid Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cepheid SWOT Analysis
2.7.4 Cepheid Product and Services
2.7.5 Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.8 BD Medical
2.8.1 BD Medical Details
2.8.2 BD Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BD Medical SWOT Analysis
2.8.4 BD Medical Product and Services
2.8.5 BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.9 BCR Diagnostics
2.9.1 BCR Diagnostics Details
2.9.2 BCR Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BCR Diagnostics SWOT Analysis
2.9.4 BCR Diagnostics Product and Services
2.9.5 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bio-Rad
2.10.1 Bio-Rad Details
2.10.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bio-Rad SWOT Analysis
2.10.4 Bio-Rad Product and Services
2.10.5 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.11 Hologic
2.11.1 Hologic Details
2.11.2 Hologic Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Hologic SWOT Analysis
2.11.4 Hologic Product and Services
2.11.5 Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.12 Danaher
2.12.1 Danaher Details
2.12.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Danaher SWOT Analysis
2.12.4 Danaher Product and Services
2.12.5 Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.13 OraSure Technologies
2.13.1 OraSure Technologies Details
2.13.2 OraSure Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 OraSure Technologies SWOT Analysis
2.13.4 OraSure Technologies Product and Services
2.13.5 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.14 GenMark Diagnostics
2.14.1 GenMark Diagnostics Details
2.14.2 GenMark Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 GenMark Diagnostics SWOT Analysis
2.14.4 GenMark Diagnostics Product and Services
2.14.5 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.15 DiaSorin
2.15.1 DiaSorin Details
2.15.2 DiaSorin Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 DiaSorin SWOT Analysis
2.15.4 DiaSorin Product and Services
2.15.5 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.16 Qualigen
2.16.1 Qualigen Details
2.16.2 Qualigen Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Qualigen SWOT Analysis
2.16.4 Qualigen Product and Services
2.16.5 Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
2.17 Quidel
2.17.1 Quidel Details
2.17.2 Quidel Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Quidel SWOT Analysis
2.17.4 Quidel Product and Services
2.17.5 Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Players (2015-2020)
3.2 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Sexually Transmitted Disease (STD) Diagnosis Players Market Share
3.3.2 Top 10 Sexually Transmitted Disease (STD) Diagnosis Players Market Share
4 North America Market Size and Forecast by Countries
4.1 North America Sexually Transmitted Disease (STD) Diagnosis Market Size by Countries (2015-2020)
4.2 North America Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast by Countries (2015-2026)
4.3 United States Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
4.4 Canada Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
4.5 Mexico Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
5 Europe Market Size and Forecast by Countries
5.1 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Countries (2015-2020)
5.2 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast by Countries (2015-2026)
5.3 Germany Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
5.4 France Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
5.5 UK Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
5.6 Russia Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
5.7 Italy Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size by Regions (2015-2020)
6.2 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast by Regions (2015-2026)
6.3 China Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
6.4 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
6.5 Korea Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
6.6 India Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
6.7 Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
7 South America Market Size and Forecast by Countries
7.1 South America Sexually Transmitted Disease (STD) Diagnosis Market Size by Countries (2015-2020)
7.2 South America Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
7.4 Argentina Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue by Regions (2015-2020)
8.2 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
8.4 UAE Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
8.5 Egypt Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
8.6 South Africa Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast (2015-2025)
9 Market Size Segment by Type
9.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast by Type (2015-2025)
9.1.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
9.1.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Forecast by Type (2020-2025)
9.2 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast by Type (2015-2025)
9.2.1 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2015-2020)
9.2.2 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size Forecast by Type (2020-2025)
10 Market Size Segment by Application
10.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast by Application (2015-2025)
10.1.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)
10.1.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Forecast by Application (2020-2025)
10.2 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size and Forecast by Application (2015-2025)
10.2.1 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2015-2020)
10.2.2 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size Forecast by Application (2020-2025)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US
List of Tables
Table 1. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Sexually Transmitted Disease (STD) Diagnosis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Regions (2015-2020)
Table 7. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Regions (2020-2025)
Table 9. Abbott Corporate Information, Location and Competitors
Table 10. Abbott Major Business
Table 11. Abbott Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 12. Abbott SWOT Analysis
Table 13. Abbott Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 14. Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 15. BioMérieux Corporate Information, Location and Competitors
Table 16. BioMérieux Major Business
Table 17. BioMérieux Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2018-2019)
Table 18. BioMérieux SWOT Analysis
Table 19. BioMérieux Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 20. BioMérieux Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 21. Aposcience Corporate Information, Location and Competitors
Table 22. Aposcience Major Business
Table 23. Aposcience Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 24. Aposcience SWOT Analysis
Table 25. Aposcience Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 26. Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 27. Roche Corporate Information, Location and Competitors
Table 28. Roche Major Business
Table 29. Roche Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 30. Roche SWOT Analysis
Table 31. Roche Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 32. Roche Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 33. Biocartis Corporate Information, Location and Competitors
Table 34. Biocartis Major Business
Table 35. Biocartis Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 36. Biocartis SWOT Analysis
Table 37. Biocartis Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 38. Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 39. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 40. Thermo Fisher Scientific Major Business
Table 41. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 42. Thermo Fisher Scientific SWOT Analysis
Table 43. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 44. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 45. Cepheid Corporate Information, Location and Competitors
Table 46. Cepheid Major Business
Table 47. Cepheid Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 48. Cepheid SWOT Analysis
Table 49. Cepheid Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 50. Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 51. BD Medical Corporate Information, Location and Competitors
Table 52. BD Medical Major Business
Table 53. BD Medical Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 54. BD Medical SWOT Analysis
Table 55. BD Medical Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 56. BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 57. BCR Diagnostics Corporate Information, Location and Competitors
Table 58. BCR Diagnostics Major Business
Table 59. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 60. BCR Diagnostics SWOT Analysis
Table 61. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 62. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 63. Bio-Rad Corporate Information, Location and Competitors
Table 64. Bio-Rad Major Business
Table 65. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 66. Bio-Rad SWOT Analysis
Table 67. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 68. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 69. Hologic Corporate Information, Location and Competitors
Table 70. Hologic Major Business
Table 71. Hologic Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 72. Hologic SWOT Analysis
Table 73. Hologic Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 74. Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 75. Danaher Corporate Information, Location and Competitors
Table 76. Danaher Major Business
Table 77. Danaher Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 78. Danaher SWOT Analysis
Table 79. Danaher Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 80. Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 81. OraSure Technologies Corporate Information, Location and Competitors
Table 82. OraSure Technologies Major Business
Table 83. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 84. OraSure Technologies SWOT Analysis
Table 85. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 86. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 87. GenMark Diagnostics Corporate Information, Location and Competitors
Table 88. GenMark Diagnostics Major Business
Table 89. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 90. GenMark Diagnostics SWOT Analysis
Table 91. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 92. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 93. DiaSorin Corporate Information, Location and Competitors
Table 94. DiaSorin Major Business
Table 95. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 96. DiaSorin SWOT Analysis
Table 97. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 98. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 99. Qualigen Corporate Information, Location and Competitors
Table 100. Qualigen Major Business
Table 101. Qualigen Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 102. Qualigen SWOT Analysis
Table 103. Qualigen Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 104. Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 105. Quidel Corporate Information, Location and Competitors
Table 106. Quidel Major Business
Table 107. Quidel Sexually Transmitted Disease (STD) Diagnosis Total Revenue (USD Million) (2017-2018)
Table 108. Quidel SWOT Analysis
Table 109. Quidel Sexually Transmitted Disease (STD) Diagnosis Product and Solutions
Table 110. Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 111. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Players (2015-2020)
Table 112. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Players (2015-2020)
Table 113. Key Players Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) in Japan (2015-2020)
Table 114. Key Players Sexually Transmitted Disease (STD) Diagnosis Revenue Share in Japan (2015-2020)
Table 115. North America Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Countries (2015-2020)
Table 116. North America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2015-2020)
Table 117. North America Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Countries (2020-2026)
Table 118. North America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2020-2026)
Table 119. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Countries (2015-2020)
Table 120. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2015-2020)
Table 121. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Countries (2020-2026)
Table 122. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2020-2026)
Table 123. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Countries (2015-2020)
Table 124. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2015-2020)
Table 125. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Countries (2020-2026)
Table 126. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2020-2026)
Table 127. South America Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Countries (2015-2020)
Table 128. South America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2015-2020)
Table 129. South America Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Countries (2020-2026)
Table 130. South America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2020-2026)
Table 131. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Countries (2015-2020)
Table 132. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2015-2020)
Table 133. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Countries (2020-2026)
Table 134. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Countries (2020-2026)
Table 135. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Type (2015-2020)
Table 136. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Type (2015-2020)
Table 137. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Forecast by Type (2020-2025)
Table 138. Global Sexually Transmitted Disease (STD) Diagnosis Market Share Forecast by Type (2020-2025)
Table 139. Japan Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Type (2015-2020)
Table 140. Japan Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Type (2015-2020)
Table 141. Japan Sexually Transmitted Disease (STD) Diagnosis Revenue Forecast by Type (2020-2025)
Table 142. Japan Sexually Transmitted Disease (STD) Diagnosis Market Share Forecast by Type (2020-2025)
Table 143. Global Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Application (2015-2020)
Table 144. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Application (2015-2020)
Table 145. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Forecast by Application (2020-2025)
Table 146. Global Sexually Transmitted Disease (STD) Diagnosis Market Share Forecast by Application (2020-2025)
Table 147. Japan Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) by Application (2015-2020)
Table 148. Japan Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Application (2015-2020)
Table 149. Japan Sexually Transmitted Disease (STD) Diagnosis Revenue Forecast by Application (2020-2025)
Table 150. Japan Sexually Transmitted Disease (STD) Diagnosis Market Share Forecast by Application (2020-2025)
List of Figures
Figure 1. Sexually Transmitted Disease (STD) Diagnosis Picture
Figure 2. Global Sexually Transmitted Disease (STD) Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Type in 2019
Figure 4. Chlamydia testing Picture
Figure 5. Syphilis testing Picture
Figure 6. Gonorrhoea testing Picture
Figure 7. Herpes simplex virus testing Picture
Figure 8. Human papilloma virus testing Picture
Figure 9. Human immunodeficiency virus testing Picture
Figure 10. Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application in 2019
Figure 11. Government organizations Picture
Figure 12. Hospitals Picture
Figure 13. Diagnostic clinics Picture
Figure 14. Global Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2015-2025) (USD Million)
Figure 15. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Regions (2015-2025)
Figure 16. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Regions in 2019
Figure 17. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Regions (2020-2025)
Figure 18. North America Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. Europe Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 20. Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 21. South America Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 22. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 23. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share in 2019
Figure 25. Top 10 Players Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share in Global Market in 2019
Figure 26. Global Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) by Type (2015-2025)
Figure 27. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Application (2015-2025)
Figure 28. North America Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Countries (2015-2025)
Figure 29. North America Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Countries in 2019
Figure 30. United States Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 31. Canada Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 32. Mexico Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 33. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Countries (2015-2025)
Figure 34. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Countries in 2019
Figure 35. Germany Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 36. France Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 37. Russia Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 38. Italy Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 39. Spain Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 40. UK Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 41. Asia Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Countries (2015-2025)
Figure 42. Asia Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Countries in 2019
Figure 43. China Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 44. Japan Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 45. Korea Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 46. India Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 47. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 48. South America Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Countries (2015-2025)
Figure 49. South America Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Countries in 2019
Figure 50. Brazil Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 51. Argentina Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 52. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Countries (2015-2025)
Figure 53. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size Share by Countries in 2019
Figure 54. Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 55. UAE Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 56. Egypt Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 57. South Africa Sexually Transmitted Disease (STD) Diagnosis Market Size (USD Million) and Forecast (2015-2025)
Figure 58. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Type (2015-2020)
Figure 59. Japan Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Type (2015-2020)
Figure 60. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Application (2015-2020)
Figure 61. Japan Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Application (2015-2020)